aim
kidney
impair
observ
patient
aim
demonstr
effect
agent
remdesivir
renal
fibrosi
method
remdesivir
activ
nucleosid
metabolit
use
treat
stimul
renal
fibroblast
human
renal
epitheli
cell
cell
viabil
determin
assay
fibrot
marker
measur
western
blot
vehicl
remdesivir
given
intraperiton
inject
renal
inject
left
uret
unilater
ureter
obstruct
uuo
mice
serum
kidney
harvest
concentr
remdesivir
measur
use
lcmsm
renal
liver
function
assess
renal
fibrosi
evalu
masson
trichrom
stain
western
blot
result
remdesivir
inhibit
cell
prolifer
express
fibrot
marker
fibronectin
asma
cell
intraperiton
inject
renal
inject
remdesivir
attenu
renal
fibrosi
uuo
kidney
renal
liver
function
chang
remdesivir
treat
uuo
mice
remdesivir
detect
two
remdesivir
metabolit
detect
inject
conclus
remdesivir
inhibit
renal
fibrosi
obstruct
kidney
authorfund
right
reserv
reus
allow
without
permiss
novel
coronaviru
report
wuhan
late
decemb
rapidli
spread
rest
world
novel
coronaviru
pneumonia
becom
worldwid
public
health
event
due
rapid
increas
new
case
high
sever
mortal
latest
research
show
patient
intens
care
unit
older
median
age
vs
like
comorbid
vs
patient
intens
care
unit
suggest
elderli
peopl
patient
underli
diseas
higher
diseas
sever
chronic
kidney
diseas
ckd
common
disord
preval
ckd
around
adult
thu
ckd
patient
combin
drawn
enough
attent
nephrologist
worth
note
caus
pneumonia
also
damag
organ
heart
liver
kidney
angiotensinconvert
enzym
mediat
entri
coronaviru
human
cell
found
highli
express
renal
tubular
cell
impli
may
directli
bind
cell
kidney
thu
induc
kidney
injuri
inde
clinic
studi
report
patient
exhibit
acut
renal
failur
arf
elderli
patient
year
like
develop
arf
vs
immunohistochemistri
analysi
reveal
antigen
accumul
renal
tubul
anoth
clinic
studi
patient
show
proteinuria
occur
patient
patient
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
elev
plasma
creatinin
urea
nitrogen
level
respect
consecut
cohort
studi
patient
show
preval
renal
impair
high
associ
inhospit
death
therefor
enough
attent
paid
kidney
protect
patient
effect
agent
kidney
also
concern
renal
interstiti
fibrosi
common
pathway
main
patholog
basi
progress
variou
chronic
kidney
diseas
endstag
renal
diseas
esrd
character
excess
deposit
extracellular
matrix
kidney
lead
complet
loss
renal
function
loss
renal
tubul
drive
develop
renal
interstiti
fibrosi
produc
larg
number
profibrot
factor
shown
sever
anim
model
signal
pathway
play
key
role
renal
fibrosi
remdesivir
nucleosid
analogu
design
treatment
sever
acut
respiratori
syndrom
coronaviru
sar
middl
east
respiratori
syndrom
mer
ebola
viru
anabol
activ
triphosph
metabolit
incorpor
newli
synthes
rna
strand
viru
substrat
viral
rnadepend
rna
synthetas
rdrp
therebi
prematur
termin
viral
rna
transcript
vitro
studi
show
remdesivir
effect
inhibit
infect
singl
case
studi
show
treatment
remdesivir
improv
clinic
condit
first
sever
infect
patient
unit
state
hour
current
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
activ
metabolit
remdesivir
use
treat
stimul
rat
renal
interstiti
fibroblast
huamn
renal
epitheli
cell
figur
test
direct
effect
remdesivir
vitro
hour
treatment
remdesivir
slightli
inhibit
cell
prolifer
stimul
cell
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
highest
concentr
although
signific
differ
figur
inhibit
fn
sma
express
remdesivir
observ
start
figur
figur
show
treatment
remdesivir
significantli
inhibit
cell
prolifer
highest
concentr
remdesivir
normal
cell
morpholog
observ
concentr
express
fn
sma
significantli
downregul
remdesivir
start
figur
mous
renal
fibrosi
model
establish
uuo
oper
one
day
sham
uuo
oper
mice
treat
vehicl
remdesivir
day
treatment
remdesivir
effect
bodi
weight
sham
uuo
mice
mice
surviv
treatment
data
shown
mild
interstiti
fibrosi
observ
vehicl
treat
uuo
mice
attenu
remdesivir
figur
protein
express
fn
collageni
coli
sma
upregul
uuo
mous
kidney
compar
sham
oper
mous
kidney
treatment
remdesivir
significantli
reduc
express
profibrot
protein
uuo
mous
kidney
figur
liver
function
alt
ast
renal
function
scr
bun
determin
remdesivir
effect
either
liver
function
renal
function
figur
serum
kidney
concentr
remdesivir
two
metabolit
remdesivir
alamet
determin
lcmsm
remdesivir
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
effect
remdesivir
renal
fibrosi
current
unknown
present
studi
show
remdesivir
inhibit
renal
fibrosi
first
treatment
remdesivir
activ
metabolit
inhibit
fibrosi
two
cellular
model
renal
fibrosi
second
systemat
administr
remdesivir
inhibit
renal
fibrosi
shown
masson
stain
western
blot
third
local
infus
remdesivir
uuo
kidney
reveal
antifibrot
effect
remdesivir
limit
studi
uuo
model
suitabl
studi
pharmaceut
effect
renal
function
uuo
model
classic
model
studi
renal
fibrosi
although
observ
slightli
increas
scr
bun
level
uuo
mice
compar
sham
mice
renal
liver
function
assess
studi
exclud
potenti
toxic
effect
remdesivir
show
effect
remdesivir
renal
liver
function
studi
concentr
remdesivir
measur
assess
dose
efficaci
howev
abl
detect
remdesivir
serum
kidney
two
differ
dose
regimen
differ
time
point
probabl
due
rapid
turnov
remdesivir
esteras
abund
blood
tissu
next
measur
concentr
two
remdesivir
metabolit
alanin
metabolit
alamet
nucleosid
metabolit
alamet
detect
hour
ip
inject
serum
kidney
sham
uuo
mice
detect
serum
kidney
hour
renal
inject
day
postinject
prove
specif
renal
infus
remdesivir
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
measur
alamet
detect
kidney
serum
hour
renal
inject
detect
day
renal
inject
conclus
show
remdesivir
inhibit
renal
fibrosi
obstruct
kidney
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
male
mice
spf
grade
purchas
hous
shanghai
model
organ
center
inc
smoc
accord
local
regul
guidelin
anesthesia
sodium
pentobarbit
ip
left
mous
kidney
vivo
drug
administr
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
intraren
administr
remdesivir
inhibit
fibrosi
uuo
mice
vehicl
remdesivir
mgml
inject
intraren
left
kidney
subject
uuo
oper
thereaft
serum
renal
tissu
collect
hour
uuo
oper
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
